TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2026
Back to search
Official data from USPTO
ALLPHASE CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000078957550Class
35, 39, 41, 42
Filing
78957550
Registration
3486543
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/14/2026
Trademark type
Combined
Nice classes
35, 39, 41, 42
Filing date
08/22/2006
Registration date
08/12/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/21/2018
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/05/2001
First use in commerce
2003-04-00
Drawing code
3
Owner type
11
Owner location
OTTAWA, ON, CA
Examiner
PINO, BRIAN
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a stylized leaf above the word "ALLPHASE CLINICAL RESEARCH".
Holders and representatives
Holders
ALLPHASE CLINICAL RESEARCH SERVICES INC.
Allphase Clinical Research (US), Inc.
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 35Class 39Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pre-clinical to phase four clinical trial management servicespre-study document collection and reviewsite selectionvisits and auditssite complianceproject tracking and monitoring reportsnegotiation and administration of investigator grantslabelingpackagingdistributioncoordination and tracking of clinical trial products and materialsregulatory document processingcentral laboratory selection and coordination; pre-clinical to phase four clinical trial management servicesmanaging site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; pre-clinical to phase four clinical trial management servicesmanaging the development of all study related documents and materials in the nature of study protocolsamendmentspaper and electronic case report formsinformed consent formsdiary cardssafety narrativespresentation posterstechnical briefs and training manuals; pre-clinical to phase four clinical trial management servicesmanaging all aspects of studydrug reconciliationinventory and distribution reportsmanaging all aspects of clinical trialsmanaging investigatorstechniciansparticipantsethical reviewsinvestigator meetingsdatabasesstatistical analyses and reportingrandomization logisticsmedical writing servicesrecruitment of investigatorstechnicians and participants; providing data management services in the medicalpharmaceutical and biotechnological field
Class 39
Clinical supply storage in the field of clinical and medical supplies
Class 41
Providing training in the field of clinical trials and clinical trial management for the pharmaceutical and biotechnological industries
Class 42
Medical and scientific research consulting regarding pre-clinical to phase four clinical trials; regulatory affairsreviewing standards and practices to assure compliance with clinical trial laws and regulations; providing quality assurance services in the pharmaceutical and biotechnological industries
Publications
History of USPTO decisions and trademark events.
40 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/29/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/21/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/21/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/21/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/21/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
08/10/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/12/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/23/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/23/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/23/2014
E815
TEAS SECTION 8 & 15 RECEIVED
08/08/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/08/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/07/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/09/2008
IUAF
USE AMENDMENT FILED
06/06/2008
EISU
TEAS STATEMENT OF USE RECEIVED
06/06/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/05/2008
PUBO
PUBLISHED FOR OPPOSITION
11/13/2007
NPUB
NOTICE OF PUBLICATION
10/24/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/07/2007
ALIE
ASSIGNED TO LIE
10/07/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/23/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/23/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2007
GNRT
NON-FINAL ACTION E-MAILED
01/23/2007
CNRT
NON-FINAL ACTION WRITTEN
01/23/2007
DOCK
ASSIGNED TO EXAMINER
01/17/2007
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
08/29/2006
NWAP
NEW APPLICATION ENTERED
08/28/2006
Continuous trademark protection
Get notified about every new filing that threatens ALLPHASE CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.